Gcbc Vaccines Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.01 Cr
- Company Age 1 Year 3 Months
About Gcbc Vaccines
Gcbc Vaccines Private Limited (GVPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 October 2023 (One year and three months 28 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Wood Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Penmetsa Ravindranath, Koduru Reddy, Viswanath Chibrolu, and Two other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U20299TS2023PTC178588
- Company No.
178588
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Gcbc Vaccines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Penmetsa Ravindranath  | Managing Director | 20-Jun-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koduru Reddy  | Director | 20-Jun-2024 | Current |
| Viswanath Chibrolu | Director | 20-Jun-2024 | Current |
| Dosapati Rao | Additional Director | 29-Aug-2024 | Current |
| Radha Mantena | Director | 29-Jan-2024 | Current |
Financial Performance of Gcbc Vaccines.
Enhance accessibility to Gcbc Vaccines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gcbc Vaccines?
Unlock access to Gcbc Vaccines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Diabetomics Medical Private LimitedKoduru Reddy is a mutual person
Valar Capital Advisory LlpPenmetsa Ravindranath is a mutual person
Ksk Energy Ventures LimitedPenmetsa Ravindranath is a mutual person
Ahlada Engineers LimitedKoduru Reddy is a mutual person
Dhananjaya Properties LlpPenmetsa Ravindranath is a mutual person
- Markanday Properties Llp
Penmetsa Ravindranath is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gcbc Vaccines?
Unlock and access historical data on people associated with Gcbc Vaccines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gcbc Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gcbc Vaccines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
